{"id":"https://openalex.org/W4281870802","doi":"https://doi.org/10.1080/13543776.2022.2083502","title":"Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022","display_name":"Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022","publication_year":2022,"publication_date":"2022-05-26","ids":{"openalex":"https://openalex.org/W4281870802","doi":"https://doi.org/10.1080/13543776.2022.2083502","pmid":"https://pubmed.ncbi.nlm.nih.gov/35616541"},"language":"en","primary_location":{"id":"doi:10.1080/13543776.2022.2083502","doi":"https://doi.org/10.1080/13543776.2022.2083502","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543776.2022.2083502","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085048207","display_name":"Sridhar Goud Nerella","orcid":"https://orcid.org/0000-0002-0132-9516","observed_orcids":["https://orcid.org/0000-0002-0132-9516"]},"institutions":[{"id":"https://openalex.org/I4210146715","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/040dgqr26","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210146715"]},{"id":"https://openalex.org/I699696","display_name":"National Institute of Mental Health and Neurosciences","ror":"https://ror.org/0405n5e57","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I699696"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sridhar Goud Nerella","raw_affiliation_strings":["Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India","Department of Neuroimaging and Interventional Radiology (NI & IR), National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India"],"raw_orcid":"https://orcid.org/0000-0002-0132-9516","affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India","institution_ids":["https://openalex.org/I4210146715"]},{"raw_affiliation_string":"Department of Neuroimaging and Interventional Radiology (NI & IR), National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India","institution_ids":["https://openalex.org/I699696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058918294","display_name":"Priti Singh","orcid":"https://orcid.org/0000-0002-9997-212X","observed_orcids":["https://orcid.org/0000-0002-9997-212X"]},"institutions":[{"id":"https://openalex.org/I4210146715","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/040dgqr26","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210146715"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Priti Singh","raw_affiliation_strings":["Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India","institution_ids":["https://openalex.org/I4210146715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078115150","display_name":"Mohammed Arifuddin","orcid":"https://orcid.org/0000-0002-0158-5683","observed_orcids":["https://orcid.org/0000-0002-0158-5683"]},"institutions":[{"id":"https://openalex.org/I3133391162","display_name":"Maulana Azad National Urdu University","ror":"https://ror.org/020an1644","country_code":"IN","type":"education","lineage":["https://openalex.org/I3133391162"]},{"id":"https://openalex.org/I4210146715","display_name":"National Institute of Pharmaceutical Education and Research","ror":"https://ror.org/040dgqr26","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210146715"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Mohammed Arifuddin","raw_affiliation_strings":["Department of Chemistry, Directorate of Distance Education, Maulana Azad National Urdu University, Gachibowli, Hyderabad, T.S.India","Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Directorate of Distance Education, Maulana Azad National Urdu University, Gachibowli, Hyderabad, T.S.India","institution_ids":["https://openalex.org/I3133391162"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India","institution_ids":["https://openalex.org/I4210146715"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035013697","display_name":"Claudiu Trandafir Supuran","orcid":"https://orcid.org/0000-0003-4262-0323","observed_orcids":["https://orcid.org/0000-0003-4262-0323"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Claudiu T Supuran","raw_affiliation_strings":["Neurofarba Department, Universit\u00e0 degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sesto Fiorentino, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurofarba Department, Universit\u00e0 degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sesto Fiorentino, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5035013697","https://openalex.org/A5078115150"],"corresponding_institution_ids":["https://openalex.org/I3133391162","https://openalex.org/I4210146715","https://openalex.org/I45084792"],"apc_list":null,"apc_paid":null,"fwci":2.6471,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.92337704,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"32","issue":"8","first_page":"833","last_page":"847"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbonic-anhydrase-ix","display_name":"carbonic anhydrase IX","score":0.9110000133514404},{"id":"https://openalex.org/keywords/carbonic-anhydrase-xii","display_name":"carbonic anhydrase XII","score":1.0},{"id":"https://openalex.org/keywords/carbonic-anhydrase-inhibitors","display_name":"carbonic anhydrase inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/anticancer-drug-development","display_name":"anticancer drug development","score":0.7179999947547913},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.7950000166893005},{"id":"https://openalex.org/keywords/isoform-selective-inhibitors","display_name":"isoform-selective inhibitors","score":0.7269999980926514},{"id":"https://openalex.org/keywords/sulfonamides","display_name":"sulfonamides","score":0.8569999933242798},{"id":"https://openalex.org/keywords/sulfamates","display_name":"sulfamates","score":0.8399999737739563},{"id":"https://openalex.org/keywords/benzoxaboroles","display_name":"benzoxaboroles","score":0.9520000219345093},{"id":"https://openalex.org/keywords/selenols","display_name":"selenols","score":0.8790000081062317},{"id":"https://openalex.org/keywords/coumarins","display_name":"coumarins","score":0.7789999842643738},{"id":"https://openalex.org/keywords/isocoumarins","display_name":"isocoumarins","score":0.8159999847412109},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7770000100135803},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8880000114440918},{"id":"https://openalex.org/keywords/slc-0111","display_name":"SLC-0111","score":0.9089999794960022},{"id":"https://openalex.org/keywords/patents","display_name":"patents","score":0.3610000014305115},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C2781200679","wikidata":"https://www.wikidata.org/wiki/Q3048282","display_name":"Sulfamide","level":2,"score":0.7919526100158691},{"id":"https://openalex.org/C2775914622","wikidata":"https://www.wikidata.org/wiki/Q284089","display_name":"Carbonic anhydrase","level":3,"score":0.743000864982605},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.550462007522583},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.48640871047973633},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.45695024728775024},{"id":"https://openalex.org/C2781039511","wikidata":"https://www.wikidata.org/wiki/Q3208529","display_name":"Sulfonamide","level":2,"score":0.4414921700954437},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4249446392059326},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4079648554325104},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37716200947761536},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3710249066352844},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26428455114364624},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.2023645043373108},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071231","descriptor_name":"Carbonic Anhydrase IX","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002257","descriptor_name":"Carbonic Anhydrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/13543776.2022.2083502","doi":"https://doi.org/10.1080/13543776.2022.2083502","is_oa":false,"landing_page_url":"https://doi.org/10.1080/13543776.2022.2083502","pdf_url":null,"source":{"id":"https://openalex.org/S3784663","display_name":"Expert Opinion on Therapeutic Patents","issn_l":"1354-3776","issn":["1354-3776","1744-7674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Patents","raw_type":"journal-article"},{"id":"pmid:35616541","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35616541","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic patents","raw_type":"Journal Article"},{"id":"pmh:oai:flore.unifi.it:2158/1306041","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2158/1306041","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":69,"referenced_works":["https://openalex.org/W87335445","https://openalex.org/W1492765754","https://openalex.org/W1969638732","https://openalex.org/W1978915600","https://openalex.org/W1990923495","https://openalex.org/W1993105964","https://openalex.org/W1997183854","https://openalex.org/W2000582156","https://openalex.org/W2012506672","https://openalex.org/W2019602861","https://openalex.org/W2028109808","https://openalex.org/W2034434306","https://openalex.org/W2047178318","https://openalex.org/W2051349300","https://openalex.org/W2069339816","https://openalex.org/W2077635615","https://openalex.org/W2077687384","https://openalex.org/W2087457173","https://openalex.org/W2088350865","https://openalex.org/W2098131572","https://openalex.org/W2101908524","https://openalex.org/W2116533349","https://openalex.org/W2138262815","https://openalex.org/W2156387230","https://openalex.org/W2158838439","https://openalex.org/W2397681412","https://openalex.org/W2471456962","https://openalex.org/W2605693728","https://openalex.org/W2703842945","https://openalex.org/W2792231238","https://openalex.org/W2793047804","https://openalex.org/W2887621482","https://openalex.org/W2944503022","https://openalex.org/W2980180521","https://openalex.org/W2985820939","https://openalex.org/W3001110109","https://openalex.org/W3014500359","https://openalex.org/W3023746940","https://openalex.org/W3033841507","https://openalex.org/W3044751445","https://openalex.org/W3047040017","https://openalex.org/W3081248824","https://openalex.org/W3083967097","https://openalex.org/W3092990449","https://openalex.org/W3112626892","https://openalex.org/W3120983042","https://openalex.org/W3133227992","https://openalex.org/W3135228027","https://openalex.org/W3163437223","https://openalex.org/W3195000164","https://openalex.org/W3196986287","https://openalex.org/W3202694306","https://openalex.org/W3211697764","https://openalex.org/W3214030463","https://openalex.org/W4200155334","https://openalex.org/W4200247137","https://openalex.org/W4200316959","https://openalex.org/W4200439189","https://openalex.org/W4200449351","https://openalex.org/W4205134789","https://openalex.org/W4205642648","https://openalex.org/W4206011470","https://openalex.org/W4212867389","https://openalex.org/W4212915892","https://openalex.org/W4213041181","https://openalex.org/W4220861340","https://openalex.org/W4220882437","https://openalex.org/W4229459668","https://openalex.org/W6902051299"],"related_works":["https://openalex.org/W1981283595","https://openalex.org/W2887621482","https://openalex.org/W2119488344","https://openalex.org/W7133352365","https://openalex.org/W4390988091","https://openalex.org/W2108905683","https://openalex.org/W4386592270","https://openalex.org/W2051444978","https://openalex.org/W1993315977","https://openalex.org/W2104030311"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Cancer":[1],"affects":[2],"an":[3,11],"increasing":[4],"number":[5],"of":[6,76,87,112,179],"patients":[7],"each":[8],"year":[9],"with":[10],"unacceptable":[12],"death":[13],"toll":[14],"worldwide.":[15],"A":[16],"new":[17],"therapeutic":[18],"approach":[19],"to":[20,109,119,164],"combat":[21],"tumors":[22],"consists":[23],"in":[24,41,46,73,171],"targeting":[25,66],"human":[26],"carbonic":[27],"anhydrase":[28],"(hCA,":[29],"EC":[30],"4.2.1.1)":[31],"isoforms":[32,97],"IX":[33],"and":[34,51,61,70,100,128,145,156],"XII,":[35],"which":[36,107],"are":[37,78],"tumor-associated,":[38],"overexpressed":[39],"enzymes":[40,69],"hypoxic":[42],"tumors,":[43],"being":[44],"involved":[45],"metabolism,":[47],"pH":[48],"regulation,":[49],"ferroptosis,":[50],"overall":[52],"tumor":[53],"progression.":[54],"AREAS":[55],"COVERED:":[56],"Small":[57],"molecule":[58,116],"hCA":[59,88,98],"IX/XII":[60],"antibody":[62],"drug":[63,104],"conjugate":[64],"inhibitors":[65,117,135],"the":[67,74,94,110,165,168,177],"two":[68],"their":[71],"applications":[72],"management":[75,178],"cancer":[77],"discussed.":[79],"EXPERT":[80],"OPINION:":[81],"The":[82,159],"available":[83],"3D":[84],"crystal":[85],"structures":[86],"IX,":[89],"XII":[90],"as":[91,93,139,141,150],"well":[92,140],"off":[95],"target":[96],"I":[99],"II,":[101],"afforded":[102],"structure-based":[103],"design":[105],"opportunities,":[106],"led":[108],"development":[111],"various":[113],"isoform-selective":[114],"small":[115,134],"belonging":[118,163],"diverse":[120],"classes":[121],"(sulfonamides,":[122],"sulfamates,":[123],"benzoxaboroles,":[124],"selenols,":[125],"coumarins,":[126],"sulfocoumarins,":[127],"isocoumarins).":[129],"Many":[130],"patents":[131],"focused":[132],"on":[133],"containing":[136],"sulfonamide/sulfamide/sulfamide":[137],"derivatives":[138],"hybrids":[142],"incorporating":[143],"sulfonamides":[144],"different":[146],"antitumor":[147],"chemotypes,":[148],"such":[149],"cytotoxic":[151],"drugs,":[152],"kinase/telomerase":[153],"inhibitors,":[154],"P-gp":[155],"thioredoxin":[157],"inhibitors.":[158],"most":[160],"investigated":[161],"candidate":[162],"class":[166],"is":[167],"sulfonamide":[169],"SLC-0111,":[170],"Phase":[172],"Ib/II":[173],"clinical":[174],"trials":[175],"for":[176],"advanced,":[180],"metastatic":[181],"solid":[182],"tumors.":[183]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-06-13T00:00:00"}